PATENT CLAIM ANALYSIS

Application Number: 16233890
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "100000"]

Abstract:
The present invention relates to a glucagon derivative, a conjugate thereof, and a composition comprising the same, and a therapeutic use thereof, and in particular, for metabolic syndrome, hypoglycemia, and congenital hyperinsulinism.

Claim (Index 88):
The method of  claim 83 , wherein the metabolic syndrome is selected from the group consisting of impaired glucose tolerance, hypercholesterolemia, dyslipidemia, obesity, diabetes, hypertension, nonalcoholic steatohepatitis (NASH), atherosclerosis caused by dyslipidemia, atherosclerosis, arteriosclerosis, coronary heart disease, and stroke.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.48148
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15740668', '13810999', '16024014', '15313501', '15086499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8341612127162017
- 35 USC 102 Novelty (BERT): 0.659073580665063
- Combined Prediction Score: 0.8166524495110878
- Mean Citation Score: 452.842674
- Max Citation Score: 747.8688
- Similarity Product: 602.5280735790253

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test